Promise Bio Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $8.7M

  • Investors
  • 6

Promise Bio General Information

Description

Operator of an artificial intelligence-based healthcare platform intended to treat lingering diseases. The company specializes in harnessing complex artificial intelligence biomarker discovery technology to optimize personalized treatment plans and facilitate care, enabling patients to get affordable treatment for chronic diseases and improve their health.

Contact Information

Website
www.promise.bio
Formerly Known As
PromiseBio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 90 Ahad Haam
  • Tel Aviv 6520711
  • Israel
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Digital Health, Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • 90 Ahad Haam
  • Tel Aviv 6520711
  • Israel

Promise Bio Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Promise Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 16-Dec-2024 $8.7M Completed Startup
2. Accelerator/Incubator 13-Oct-2023 Completed Startup
1. Seed Round 01-Apr-2023 $8.3M $8.3M Completed Startup
To view Promise Bio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Promise Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Promise Bio Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
AION Labs Accelerator/Incubator Minority
Innovation Authority Government
Endless Frontier Labs Accelerator/Incubator
AstraZeneca Corporation Minority
Awz Ventures Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Promise Bio FAQs

  • When was Promise Bio founded?

    Promise Bio was founded in 2023.

  • Where is Promise Bio headquartered?

    Promise Bio is headquartered in Tel Aviv, Israel.

  • What is the size of Promise Bio?

    Promise Bio has 13 total employees.

  • What industry is Promise Bio in?

    Promise Bio’s primary industry is Drug Discovery.

  • Is Promise Bio a private or public company?

    Promise Bio is a Private company.

  • What is Promise Bio’s current revenue?

    The current revenue for Promise Bio is .

  • How much funding has Promise Bio raised over time?

    Promise Bio has raised $17M.

  • Who are Promise Bio’s investors?

    AION Labs, Innovation Authority, Endless Frontier Labs, AstraZeneca, and Awz Ventures are 5 of 6 investors who have invested in Promise Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process